Cellen Therapeutics is an independent, UK-based company working with industry and research partners to ensure patients receive products compliant with EU GACP, EU GMP and EU GDP standards. Cellen is also a founding member of Project Twenty21.
Cellen Therapeutics was founded by NHS specialists with a mission to improve the health and wellbeing of people living with chronic conditions, by improving access to pharmaceutical-grade Medical Cannabis.
Cellen’s MedCanHub is a platform developed by NHS consultants, to increase the proficiency and confidence of doctors to prescribe in the UK. The platform is available to use for free by GMC registered doctors and GPhC registered pharmacists.
The MedCanHub supports clinical teams with tools such as: